Immunological reversal of digitalis toxicity by Fab fragments of digoxin-specific antibodies
Daniel M. Cooper, James D. Maloney, Lynn A. Cooper, J. R. Hodgman, LON W. CASTLE
Abstract
Daniel M. Cooper, James D. Maloney, Lynn A. Cooper, J. R. Hodgman, LON W. CASTLE
Abstract
Severe digitalis toxicity is associated with a high mortality. We present a case of advanced digoxin toxicity successfully treated with digoxin-specific antibody Fab fragments, and discuss its mechanism of action. A review of the pharmacokinetics of digitalis as well as the mechanisms of cardiotoxicity and its conventional treatment is presented.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Severe digitalis toxicity is associated with a high mortality. We present a case of advanced digoxin toxicity successfully treated with digoxin-specific antibody Fab fragments, and discuss its mechanism of action. A review of the pharmacokinetics of digitalis as well as the mechanisms of cardiotoxicity and its conventional treatment is presented.
Key concepts: Medicine, Digoxin, Antibody, Digitalis, Digitalis Toxicity, Toxicity, Pharmacology, Immunology